Cargando…

Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model

Gardeniae Fructus (GF, the dried ripe fruits of Gardenia jasminoides Ellis) has traditionally been used to treat various diseases in East Asian countries, such as liver disease. Silymarin is a well-known medicine used to treat numerous liver diseases globally. The present study was purposed to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin A, Shin, Mi-Rae, Choi, JeongWon, Kim, MinJu, Park, Hae-Jin, Roh, Seong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854785/
https://www.ncbi.nlm.nih.gov/pubmed/36670959
http://dx.doi.org/10.3390/antiox12010097
_version_ 1784873209335644160
author Lee, Jin A
Shin, Mi-Rae
Choi, JeongWon
Kim, MinJu
Park, Hae-Jin
Roh, Seong-Soo
author_facet Lee, Jin A
Shin, Mi-Rae
Choi, JeongWon
Kim, MinJu
Park, Hae-Jin
Roh, Seong-Soo
author_sort Lee, Jin A
collection PubMed
description Gardeniae Fructus (GF, the dried ripe fruits of Gardenia jasminoides Ellis) has traditionally been used to treat various diseases in East Asian countries, such as liver disease. Silymarin is a well-known medicine used to treat numerous liver diseases globally. The present study was purposed to evaluate the synergistic effects of GF and silymarin on the thioacetamide (TAA)-induced liver fibrosis of a mouse model. Mice were orally administered with distilled water, GF (100 mg/kg, GF 100), silymarin (100 mg/kg, Sily 100), and GF and silymarin mixtures (50 and 100 mg/kg, GS 50 and 100). The GS group showed remarkable amelioration of liver injury in the serum levels and histopathology by observing the inflamed cell infiltrations and decreases in necrotic bodies through the liver tissue. TAA caused liver tissue oxidation, which was evidenced by the abnormal statuses of lipid peroxidation and deteriorations in the total glutathione in the hepatic protein levels; moreover, the immunohistochemistry supported the increases in the positive signals against 4-hydroxyneal and 8-OHdG through the liver tissue. These alterations corresponded well to hepatic inflammation by an increase in F4/80 positive cells and increases in pro-inflammatory cytokines in the hepatic protein levels; however, administration with GS, especially the high dose group, not only remarkably reduced oxidative stress and DNA damage in the liver cells but also considerably diminished pro-inflammatory cytokines, which were driven by Kupffer cell activations, as compared with each of the single treatment groups. The pharmacological properties of GS prolonged liver fibrosis by the amelioration of hepatic stellate cells’ (HSCs’) activation that is dominantly expressed by huge extracellular matrix (ECM) molecules including α-smooth muscle actin, and collagen type1 and 3, respectively. We further figured out that GS ameliorated HSCs activated by the regulation of Sirtuin 1 (Sirt1) activities in the hepatic protein levels, and this finding excellently reenacted the transforming growth factor-β-treated LX-2-cells-induced cell death signals depending on the Sirt1 activities. Future studies need to reveal the pharmacological roles of GS on the specific cell types during the liver fibrosis condition.
format Online
Article
Text
id pubmed-9854785
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98547852023-01-21 Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model Lee, Jin A Shin, Mi-Rae Choi, JeongWon Kim, MinJu Park, Hae-Jin Roh, Seong-Soo Antioxidants (Basel) Article Gardeniae Fructus (GF, the dried ripe fruits of Gardenia jasminoides Ellis) has traditionally been used to treat various diseases in East Asian countries, such as liver disease. Silymarin is a well-known medicine used to treat numerous liver diseases globally. The present study was purposed to evaluate the synergistic effects of GF and silymarin on the thioacetamide (TAA)-induced liver fibrosis of a mouse model. Mice were orally administered with distilled water, GF (100 mg/kg, GF 100), silymarin (100 mg/kg, Sily 100), and GF and silymarin mixtures (50 and 100 mg/kg, GS 50 and 100). The GS group showed remarkable amelioration of liver injury in the serum levels and histopathology by observing the inflamed cell infiltrations and decreases in necrotic bodies through the liver tissue. TAA caused liver tissue oxidation, which was evidenced by the abnormal statuses of lipid peroxidation and deteriorations in the total glutathione in the hepatic protein levels; moreover, the immunohistochemistry supported the increases in the positive signals against 4-hydroxyneal and 8-OHdG through the liver tissue. These alterations corresponded well to hepatic inflammation by an increase in F4/80 positive cells and increases in pro-inflammatory cytokines in the hepatic protein levels; however, administration with GS, especially the high dose group, not only remarkably reduced oxidative stress and DNA damage in the liver cells but also considerably diminished pro-inflammatory cytokines, which were driven by Kupffer cell activations, as compared with each of the single treatment groups. The pharmacological properties of GS prolonged liver fibrosis by the amelioration of hepatic stellate cells’ (HSCs’) activation that is dominantly expressed by huge extracellular matrix (ECM) molecules including α-smooth muscle actin, and collagen type1 and 3, respectively. We further figured out that GS ameliorated HSCs activated by the regulation of Sirtuin 1 (Sirt1) activities in the hepatic protein levels, and this finding excellently reenacted the transforming growth factor-β-treated LX-2-cells-induced cell death signals depending on the Sirt1 activities. Future studies need to reveal the pharmacological roles of GS on the specific cell types during the liver fibrosis condition. MDPI 2022-12-30 /pmc/articles/PMC9854785/ /pubmed/36670959 http://dx.doi.org/10.3390/antiox12010097 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Jin A
Shin, Mi-Rae
Choi, JeongWon
Kim, MinJu
Park, Hae-Jin
Roh, Seong-Soo
Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model
title Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model
title_full Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model
title_fullStr Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model
title_full_unstemmed Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model
title_short Co-Treatments of Gardeniae Fructus and Silymarin Ameliorates Excessive Oxidative Stress-Driven Liver Fibrosis by Regulation of Hepatic Sirtuin1 Activities Using Thioacetamide-Induced Mice Model
title_sort co-treatments of gardeniae fructus and silymarin ameliorates excessive oxidative stress-driven liver fibrosis by regulation of hepatic sirtuin1 activities using thioacetamide-induced mice model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854785/
https://www.ncbi.nlm.nih.gov/pubmed/36670959
http://dx.doi.org/10.3390/antiox12010097
work_keys_str_mv AT leejina cotreatmentsofgardeniaefructusandsilymarinamelioratesexcessiveoxidativestressdrivenliverfibrosisbyregulationofhepaticsirtuin1activitiesusingthioacetamideinducedmicemodel
AT shinmirae cotreatmentsofgardeniaefructusandsilymarinamelioratesexcessiveoxidativestressdrivenliverfibrosisbyregulationofhepaticsirtuin1activitiesusingthioacetamideinducedmicemodel
AT choijeongwon cotreatmentsofgardeniaefructusandsilymarinamelioratesexcessiveoxidativestressdrivenliverfibrosisbyregulationofhepaticsirtuin1activitiesusingthioacetamideinducedmicemodel
AT kimminju cotreatmentsofgardeniaefructusandsilymarinamelioratesexcessiveoxidativestressdrivenliverfibrosisbyregulationofhepaticsirtuin1activitiesusingthioacetamideinducedmicemodel
AT parkhaejin cotreatmentsofgardeniaefructusandsilymarinamelioratesexcessiveoxidativestressdrivenliverfibrosisbyregulationofhepaticsirtuin1activitiesusingthioacetamideinducedmicemodel
AT rohseongsoo cotreatmentsofgardeniaefructusandsilymarinamelioratesexcessiveoxidativestressdrivenliverfibrosisbyregulationofhepaticsirtuin1activitiesusingthioacetamideinducedmicemodel